Welcome to SDEE

Welcome to San Diego Entrepreneurs Exchange! 

The San Diego Entrepreneurs Exchange (SDEE) is a nonprofit 501(c)(3) organization run by local entrepreneurs for entrepreneurs and pre-entrepreneurs interested in Life Sciences, Biotech, Pharma, Medical Devices, Tech and Alternative Energy. SDEE was founded to provide a voice and resources for early stage startups, to encourage new entrepreneurs, and sponsor networking and educational services to help develop skills necessary to bring new businesses and funding to the San Diego area. 

SDEE Businesses Directory SDEE Consultants Directory


ALT logo


Takeda San Diego


Barney and Barney TriNet Alexandria


Knobe MartensDuane Morris MaxCyte

  • Wednesday, October 17, 2018 at 05:00 PM · 82 rsvps

    Founders Tales

      Come and hear local San Diego Biotech leaders speak about their experiences with starting companies, building teams, raising money, and developing their businesses Featured Speakers:   Samantha Urban, CEO & Founder: Urban Translations   Samantha is the CEO and founder of Urban Translations, the leading provider of a multilingual in-room digital concierge platform for hotels & resorts.  Samantha has been involved in the tech industry for over 18 years.  She speaks regularly at universities and various conferences around the world.  She started her career as a Software Engineer and a Patent Examiner for Graphical User Interfaces.  She moved into product management for the third largest social network, myYearbook.com.  Her contributions helped the company exit for $100M, and then she transitioned to managing a digital ad agency working directly with Facebook.  After the sale of that agency, Samantha focused all efforts on her current software company.  Headquartered in San Diego, Samantha advises many hospitality groups, technology companies and always finds time to inspire young, women engineers.   Fabio C. Tucci, Ph.D., Chief Operating Officer and co-founder, Epigen Biosciences, Inc.   Dr. Tucci has over 20 years of experience in drug discovery, medicinal chemistry and organic synthesis. In this role, Dr. Tucci is responsible for managing certain aspects of the company, including project management, medicinal chemistry design, investor relations, operations and administration functions. As the Director of Chemistry at Tanabe Research Laboratories, he led the Medicinal Chemistry Department and advanced several programs on inflammation and metabolic diseases to the pipeline of Mitsubishi Tanabe Pharma Corporation in Japan. While at Neurocrine Biosciences, Dr. Tucci served as Principal Scientist in the Medicinal Chemistry Department where he was part of the team that conceived and optimized Elagolix, a potent small-molecule GnRH antagonist that has recently been approved by the FDA for human use. In addition, he was the lead medicinal chemistry scientist in the melanocortin-4 (MC4) program for obesity and cancer-cachexia and histamine-1 (H1) antagonist for insomnia. Dr. Tucci received a Ph.D. degree in organic chemistry from the Universidade de São Paulo, Brazil, and conducted postdoctoral studies at the University of Wisconsin, Madison and The Scripps Research Institute, La Jolla. He authored/co-authored over 60 peer-reviewed publications and is an inventor in over 20 patents and patent applications.   Cydne Holt, Ph.D., Chief Scientific Officer & Founder, Verogen, Inc.   After earning her PhD from Baylor College of Medicine, Cydne worked as a criminalist at the Santa Clara District Attorney Criminalistics Laboratory, and then was part of the original R&D team at Applied Biosystems that developed the first PCR amplification kits for forensic/human identification applications using capillary electrophoresis instrumentation. She later became the DNA Technical Leader and Forensic Science Division Director for the City and County of San Francisco where she worked for 10 years before joining Illumina to lead their forensic genomics business. She currently serves as the Chief Scientific Officer at Verogen, where she is focused on advancing massively parallel sequencing and other powerful tools to improve public safety and global justice.   5:00pm – 6:00pm Networking, Reception, and Exhibition; Cash Bar6:00pm – 6:10pm Introduction & 30 Second Pitch6:10pm – 7:30pm Panel Presentation and Discussion Cost: Free for SDEE members, $25 for non-members Purchase non-member tickets here Please note that free registrations are verified. If you are not a member you will be asked to pay at the door. If your SDEE membership has expired or you are not sure, please ask Danielle dhayes@sdentrepreneurs.org Exhibit tables are available to SDEE member companies  SDEE members can apply for the 30 Second Pitch  **you must sign up in advance, audience requests not accepted Contact: Danielle Hayes, dhayes@sdentrepreneurs.org Visit sdentrepreneurs.org to become a member. Event Sponsor:
    Thursday, October 18, 2018 at 05:30 PM · 54 rsvps
    New English Brewing Company in San Diego, CA

    October Happy Hour Sponsored by ALT

    Come network with your fellow San Diego entrepreneurs at Happy Hour held at the New English Brewing Company in Sorrento Valley. This month's Happy Hour is sponsored by American Laboratory Trading (ALT).  SDEE members - stop by the SDEE table, make a name tag, and exchange your business card with ALT for one free drink ticket and one free food ticket.  This month's food truck will be Papas Locas. @PapasLocasTruck Everyone is welcome (registration is free!), SDEE members get 10% drinks discount. Not a member yet? Stop at the SDEE table to learn about member benefits. You can also ask around at happy hour as our members are pleased to share their personal benefits of joining.
    Tuesday, October 23, 2018 at 12:00 PM
    Wells Fargo Bank in San Diego, CA

    Lunch and Learn with Wagenknecht IP Law Group

    Strategies for Protecting Life Science Inventions October 23, 2018 12:00pm - 1:30pm   Location: Wells Fargo Bank, 4655 Executive Drive - 2nd floor conference center, San Diego, CA 92121 Parking in Wells Fargo parking structure is covered for 2 hours ONLY if RSVPs received by October 16th Please join us for a lunch and learn to have an informal discussion about how to best strategize to protect your life science inventions and minimize costs. Please come prepared to ask questions and share you own experiences.  Agenda How to determine whether your DNA & protein sequences are eligible for patent protection Approaches for expanding patent scope to cover protein fragments & variants Steps for patenting diagnostic tests Considerations when pursuing medical treatments internationally Factors in support of keeping your platform technology as trade secret About our Speakers:              Ray Wagenknecht is a patent attorney with strong ties to San Diego's research and development community with 15 years of experience protecting and enforcing intellectual property rights.  Ray's practice includes comprehensive patent and trademark representation, including patent and trademark prosecution, due diligence, freedom to operate (FTO) analysis, and trademark opposition proceedings. Ray received his Juris Doctorate (J.D.) degree from the University of San Diego School of Law (USD), and his Bachelor of Science (B.S.) degree in Molecular Biology from the University of California, San Diego (UCSD).              Antony Novom is a patent attorney with more than 18 years of experience counseling clients in all areas of intellectual property protection, prepares and prosecutes patent applications in a wide range of technologies, including biotechnology, pharmaceuticals, medical devices, clean tech, biofuels, and electronic hardware. Antony received his Juris Doctorate (J.D.) degree from California Western School of Law, San Diego, and his Bachelor of Science (B.S.) degree in Biochemistry from the University of California, San Diego (UCSD).  Wagenknecht IP Law Group is a full-service intellectual property boutique law firm representing corporations, universities, and nonprofit institutions. The Firm has consistently been recognized as a "Top Patent Firm" by Intellectual Property Today Magazine and was awarded "Best for Medical Device Patent & Trademark Protection" from Acquisition International.   This is a free event!   RSVP by October 16th to: “Andy” Kotner   Andy@WagenIPLaw.com Please indicate food preference for Box Lunch – Chicken, Beef, or Vegetarian Please indicate if you need parking vouchers
    Thursday, November 15, 2018 at 05:30 PM · 10 rsvps
    New English Brewing Company in San Diego, CA

    November Happy Hour

    Come network with your fellow San Diego entrepreneurs at Happy Hour held at the New English Brewing Company in Sorrento Valley. Everyone is welcome (registration is free!), SDEE members get 10% drinks discount.

  • News From SDEE Members

    Pharmaceutical & Medical Device Regulatory Affairs Director

    Collidion, Inc. and it’s subsidiaries,  Plex Pharmaceuticals & Avenlogics, Inc has an immediate full-time position open for Pharmaceutical & Medical Device Regulatory Affairs Director. Position: Full-time Location: Flexible To apply, visit www.collidion.com/careers   Founded in 2015, Collidion, Inc. is a private healthcare company with two subsidiaries, Avenlogics, Inc. and Plex Pharmaceuticals. Collidion strives to improve the future of global healthcare through the acquisition, licensing, development, and commercialization of drugs and medical devices for various markets.  Collidion invests industry expertise and capital to develop these technologies into recognizable solutions for patients and medical professionals. Collidion values innovation, scientific rigor, collaboration and a passion for change.   Avenlogics, Inc., Collidion’s subsidiary, is focused on the development and commercialization of several anti-infective based products.  The Company’s pipeline of antimicrobial products addresses a growing need for alternative therapies to effectively treat infections caused by antimicrobial resistant pathogens. Collidion’s solutions include several antimicrobial platforms with potential applications in human and animal medicines, wound care, surface disinfection, and improved safety for the food supply chain. The company is located alongside with Collidion, Inc in Petaluma, CA.   Plex Pharmaceuticals is a scientifically-driven company with a vision to improve the lives of patients with complex diseases and conditions. The company is focused on the treatment of diseases generally caused by protein misfolding: ALS, Parkinson’s disease, and cataracts.  The company was founded in 2009.  Plex has a rich pipeline of drug discovery programs and a dedicated scientific team. Plex’s drug discovery lab and operations are located in San Diego, California.   PHARMACEUTICAL AND MEDICAL DEVICE REGULATORY AFFAIRS DIRECTOR   Regulatory representation and leadership to cross-functional product development teams, development of regulatory strategies and support for clinical and non-clinical development programs and marketing applications.  Responsible for project timelines and management of 510K, PMA, IND, NDA and global regulatory submissions.  Lead regulatory activities including planning and reviewing of CMC, clinical and nonclinical sections of regulatory submissions.  Plan, direct and prepare regulatory submissions (IND, NDA, IDE, 510(k), PMA) to ensure compliance with FDA and international regulations and guidelines.  Develop and maintain SOPs with an emphasis on drug and device regulations.  Perform research regarding regulatory strategic recommendations, and new and revised governmental regulations.  Conduct successful negotiations and interactions with domestic and foreign regulatory agencies on assigned projects.  Provide regulatory guidance with regard to preparation, review and approval of labeling and promotional materials.  Prepare and assist with applicable regulatory audits.  Statistical techniques.      EDUCATION REQUIREMENTS:     Minimum of B.S. in life sciences, engineering, or equivalent required.  Advanced degree preferred.      EXPERIENCE REQUIREMENTS:    Minimum 5-7 years of experience in regulatory affairs for pharmaceutical and medical device biopharmaceutical companies.  Veterinary product experience highly desirable.  Experience with successful FDA and international agency negotiations and audits.  Experience in developing and submitting successful 510(k), PMA, IND/NDA submissions with a thorough understanding of the drug and device development processes, FDA regulations and ICH guidelines.  Excellent verbal and written communication skills.      OTHER QUALIFICATIONS:    Detail oriented with well-developed organizational and analytical skills.  Experience with submitting documents in CTD and eCTD format.  Suited to working in a fast-paced, small company environment.     
    read more

    Fully equipped 1000-1500 Sq. Ft. laboratory space available for sub-lease in Sorrento Mesa area

    Plex Pharmaceuticals is interested in sub-leasing 1000-1500 Sq. Ft. of laboratory space on a month-to-month or long-term basis. The sub-lessee will have access to common laboratory equipment, chemical fume hood, tissue culture and other general lab instruments. Lab bench with 3-5 knee holes, dedicated office space, wi-fi, shared conference room, common kitchen and reception area. Interested parties please contact Sridhar Prasad at 858-733-0858 or email: sprasad@plexpharma.com
    read more
    See all news or Share Your Own News

  • Meet SDEE Community

    When and How to Develop a Regulatory Roadmap

    By Amy Duncan, Goldfish Consulting, Inc. Regulatory approval is a major inflection point and value driver for companies, yet many wait too long to develop a roadmap for success. To help put things in perspective, San Diego Entrepreneurs Exchange (SDEE) hosted a workshop, “Planning for Success: When and How to Develop a Regulatory Roadmap,” on October 9, 2018, at Hera Hub in San Diego. Leading the workshop were local experts with first-hand experience in all phases of the regulatory process for drugs and IVD/devices:  Luis Jimenez, Vice President, Business Development, Brandwood Biomedical; Jennifer Grodberg, Sr. Vice President, Regulatory Affairs and Program Management, Forge Therapeutics; and Michael Monahan, Sr. Director, Regulatory Affairs and Quality Assurance, Crinetics Pharmaceuticals. Speakers provided advice for developing a regulatory roadmap, including interactions with FDA:
    read more

    Six Tips for Collaborating with Pharma from the SDEE “Partnering Without Pitfalls” Event

    By Amy Duncan, Goldfish Consulting, Inc. Small biotechs and large pharmaceutical companies, both staffed with highly skilled scientists, often face challenges when partnering on a collaboration. To understand more about pharma partnering, San Diego Entrepreneurs Exchange (SDEE) and LaunchBio co-hosted “Partnering Without Pitfalls: Building Successful Collaborations Between Entrepreneurs and Pharma,” on September 13, 2018, at in the Illumina Theater at The Alexandria-Torrey Pines.
    read more
    See all news

Attend SDEE Events Donate | Sponsor SDEE Become a Member

Connect with SDEE

Sign Up for SDEE Newsletter


ALT San Diego


Takeda San Diego


Barney and Barney TriNet Alexandria


Knobe Martens Duane Morris MaxCyte

SDEE is a nonprofit 501(c)(3) organization founded by local San Diego entrepreneurs
in order to provide a voice for the early stage start-up, to support new entrepreneurs and their companies,
and to sponsor networking and educational events
to help develop the skills necessary to bring funding, business, and jobs to the San Diego area.

© 2015 San Diego Entrepreneurs Exchange. All Rights Reserved